ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,183.90
-0.07%
Dow Jones
38,941.34
0.15%
US Dollar vs MXN
16.93475
0.17%
Brent Oil
83.075
0.25%
Bitcoin
62,213.26
-0.19%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) Noticias

SUPN Supernus Pharmaceuticals Inc

31.115
-0.035 (-0.11%)
Última actualización: 09:59:49
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Supernus Pharmaceuticals Inc SUPN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.035 -0.11% 31.115 09:59:49
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
30.97 30.76 31.33 31.15
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202409:00PRNUSM8 Pharmaceuticals, an Acino company, signs an exclusive..
01/5/202407:00GLOBEBusy Philipps Shines Spotlight on ADHD in Women and Shares..
24/4/202415:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08/4/202407:00GLOBESupernus Provides Regulatory Update for SPN-830
06/3/202415:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
29/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202416:00EDGAR2Form 8-K - Current report
28/2/202415:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
27/2/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202415:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
26/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:27EDGAR2Form 144 - Report of proposed sale of securities
22/2/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202406:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:08EDGAR2Form 8-K - Current report
13/2/202415:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05/2/202408:21EDGAR2Form 8-K - Current report
05/2/202407:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
12/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:08EDGAR2Form 144 - Report of proposed sale of securities
26/12/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202306:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
18/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
17/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:22EDGAR2Form 144 - Report of proposed sale of securities
14/11/202313:59EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:10EDGAR2Form 8-K - Current report
08/11/202315:05GLOBESupernus Announces Third Quarter 2023 Financial Results
07/11/202315:30GLOBESupernus to Participate in the Jefferies London Healthcare..
02/11/202315:24EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados